doxazosin has been researched along with Carcinoma, Renal Cell in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two cell lines were used: renal cell carcinoma (RCC) 786-0, harboring a von Hippel-Lindau (VHL) tumor-suppressor gene mutation with a highly angiogenic phenotype, and Caki cells (no VHL mutation)." | 1.37 | Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma. ( Kyprianou, N; Sakamoto, S; Schwarze, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, S | 1 |
| Schwarze, S | 1 |
| Kyprianou, N | 1 |
| Johansson, M | 1 |
2 other studies available for doxazosin and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anoikis; Antineoplastic Agents; Carcinoma, Renal Cell; Casp | 2011 |
Lord of the rings: a promising novel treatment for renal cell carcinoma?
Topics: Adrenergic alpha-1 Receptor Antagonists; Anoikis; Antineoplastic Agents; Carcinoma, Renal Cell; Cell | 2011 |